Logo image of VROY.CA

VIZSLA ROYALTIES CORP (VROY.CA) Stock Fundamental Analysis

TSX-V:VROY - TSX Venture Exchange - CA92859L2012 - Common Stock - Currency: CAD

2.66  -0.05 (-1.85%)

Fundamental Rating

2

Taking everything into account, VROY scores 2 out of 10 in our fundamental rating. VROY was compared to 0 industry peers in the Unkown industry. The financial health of VROY is average, but there are quite some concerns on its profitability. VROY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VROY has reported negative net income.
VROY.CA Yearly Net Income VS EBIT VS OCF VS FCFVROY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 -50K -100K -150K

1.2 Ratios

Industry RankSector Rank
ROA -22.97%
ROE -23.03%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VROY.CA Yearly ROA, ROE, ROICVROY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VROY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VROY.CA Yearly Profit, Operating, Gross MarginsVROY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

VROY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VROY.CA Yearly Shares OutstandingVROY.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M 25M
VROY.CA Yearly Total Debt VS Total AssetsVROY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 100K 200K 300K

2.2 Solvency

VROY has an Altman-Z score of 5058.72. This indicates that VROY is financially healthy and has little risk of bankruptcy at the moment.
VROY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5058.72
ROIC/WACCN/A
WACCN/A
VROY.CA Yearly LT Debt VS Equity VS FCFVROY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 -500K -1M

2.3 Liquidity

VROY has a Current Ratio of 377.05. This indicates that VROY is financially healthy and has no problem in meeting its short term obligations.
VROY has a Quick Ratio of 377.05. This indicates that VROY is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 377.05
Quick Ratio 377.05
VROY.CA Yearly Current Assets VS Current LiabilitesVROY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, VROY will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.41% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y37.85%
EPS Next 2Y17.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VROY.CA Yearly Revenue VS EstimatesVROY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2M 4M 6M 8M
VROY.CA Yearly EPS VS EstimatesVROY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VROY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VROY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VROY.CA Price Earnings VS Forward Price EarningsVROY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VROY.CA Per share dataVROY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

A more expensive valuation may be justified as VROY's earnings are expected to grow with 17.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VROY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIZSLA ROYALTIES CORP

TSX-V:VROY (8/1/2025, 7:00:00 PM)

2.66

-0.05 (-1.85%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)N/A N/A
Inst Owners7.14%
Inst Owner ChangeN/A
Ins Owners2.85%
Ins Owner ChangeN/A
Market Cap177.90M
Analysts80
Price Target3.32 (24.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.04%
PT rev (3m)23.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 22.42
P/tB 22.42
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.97%
ROE -23.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 377.05
Quick Ratio 377.05
Altman-Z 5058.72
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y37.85%
EPS Next 2Y17.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9452.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-233.88%
EBIT Next 3Y-49.46%
EBIT Next 5YN/A
FCF growth 1Y-9642.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9642.11%
OCF growth 3YN/A
OCF growth 5YN/A